The guidelines, published jointly in JACC and Circulation, reflect a shift toward proactive prevention by identifying individuals with hidden high risk earlier, such as those with familial hypercholesterolemia who may have elevated LDL cholesterol from a young age.
According to the document, sustained reduction of LDL cholesterol is associated with lower risk of cardiovascular events, particularly in high-risk patients, and treatment decisions should combine lifestyle changes with medication when lifestyle adjustments alone do not meet recommended targets.
The update stresses that LDL cholesterol remains the primary target, but its interpretation must now consider the patient’s full risk profile—including diabetes, hypertension, family history, or prior cardiovascular events—meaning two people with the same LDL level may receive different recommendations based on their individual circumstances.
Experts note the change is driven by strong scientific evidence showing that lower LDL levels correlate with reduced risk of heart attack and stroke, not by industry influence or arbitrary decisions.
The recommendations aim to move beyond generic advice like “eat healthy” by offering tools to distinguish who needs only lifestyle modifications and who requires earlier medical intervention, supporting a more personalized and anticipatory approach to cardiovascular disease prevention.
